Compositions and methods for treatment of tissue

Patent metadata

Field	Value
Publication number	US-10179190-B2
Application number	US-201615167209-A
Country	US
Kind code	B2
Filing date	May 27, 2016
Priority date	May 29, 2015
Publication date	Jan 15, 2019
Grant date	Jan 15, 2019

Abstract

Methods of treating tissue of a patient, e.g., tissue of an organ such that the bladder, are described. The methods may comprise inserting a medical device within the bladder; and injecting a composition to separate a first layer of tissue from a second layer of tissue. The composition may comprise at least one polysaccharide compound having a concentration ranging from approximately 0.05% to approximately 25% by weight, with respect to the total weight of the composition. The composition may at least partially separate the first layer of tissue from the second layer of tissue. At least one of the first layer of tissue or the second layer of tissue may be a detrusor muscle tissue.

First claim

What is claimed is:

1. A method of treating tissue of a patient, the method comprising injecting a composition between a first layer of tissue and a second layer of tissue of an organ in the patient in need thereof;
wherein the composition comprises xanthan gum by weight, with respect to the total weight of the composition and wherein the xanthan gum has a molecular weight between 1×10 6 and 15×10 6 Da, and wherein the xanthan gum has a viscosity between 800 and 1200 cP; and
wherein the composition separates the first layer of tissue from the second layer of tissue of the organ.

2. The method of claim 1 , wherein the organ is a bladder, and
wherein the method includes an initial step of detecting one or more locations of abnormal contraction of the bladder, and wherein the step of injecting the composition between the first layer of tissue and the second layer of tissue includes injecting the composition between the first layer of tissue and the second layer of tissue at the one or more locations of abnormal contraction of the bladder.

3. The method of claim 2 , wherein at least one of the first layer or the second layer of tissue is a detrusor muscle tissue.

4. The method of claim 3 , wherein the contraction of the detrusor muscle tissue is reduced after the composition is injected.

5. The method of claim 1 , wherein the composition has a first viscosity before injection into the organ, and a second viscosity higher than the first viscosity after the composition is injected into the organ.

6. The method of claim 1 , wherein the composition further comprises at least one polysaccharide compound that is chosen from alginate, pectin, a glycosaminoglycan, carboxymethyl cellulose, chitosan, a salt thereof, or a combination thereof.

7. The method of claim 1 , wherein the composition further comprises alginate, and wherein the composition further comprises at least one calcium compound.

8. The method of claim 7 , wherein a molar ratio of the calcium compound to the alginate ranges from about 1:1 to about 1:3.

9. A method of treating a bladder of a patient, the method comprising:
detecting one or more locations of abnormal contraction of the bladder;
injecting a composition at the one or more locations of abnormal contraction between a first layer of tissue and a second layer of tissue of the bladder in the patient in need thereof; and measuring an average thickness of the injected composition at a time greater than approximately two months after the injection;
wherein the composition comprises xanthan gum, the concentration of the xanthan gum ranging from approximately 0.05% to approximately 1.5% by weight, with respect to the total weight of the composition; and
wherein the composition separates the first layer of tissue from the second layer of tissue.

10. The method of claim 9 , wherein the first layer of tissue is a mucosal layer, and the second layer of tissue is a muscle layer.

11. The method of claim 9 , wherein the composition further comprises alginate, and wherein the composition further comprises a calcium compound, the composition having a molar ratio of calcium compound to alginate of about 1:2.

12. The method of claim 9 , wherein the composition further comprises calcium alginate.

13. The method of claim 9 , further comprising:
mixing the xanthan gum with a second component of the composition less than approximately 20 minutes before injecting the composition.

14. A method of treating a bladder of a patient, the method comprising:
detecting one or more locations of abnormal contraction of the bladder; and
injecting a composition at the one or more locations of abnormal contraction between a first layer of tissue and a second layer of tissue of the bladder in the patient in need thereof;
wherein the composition comprises xanthan gum having a concentration ranging from approximately 0.05% to approximately 1.5% by weight, with respect to the total weight of the composition, a molecular weight of between 1×10 6 and 15×10 6 Da, and a viscosity between 800 and 1200 cP;
wherein the composition separates the first layer of tissue from the second layer of tissue; and
wherein at least one of the first layer of tissue or the second layer of tissue is a detrusor muscle tissue.

15. The method of claim 14 , further including at least one polysaccharide compound chosen from alginate, pectin, a glycosaminoglycan, carboxymethyl cellulose, chitosan, a salt thereof, or a combination thereof.

16. The method of claim 14 , wherein the composition has a first viscosity before injection into the bladder, and a second viscosity higher than the first viscosity after injection into the bladder.

17. The method of claim 14 , wherein the composition forms a gel between the first tissue layer and the second tissue layer.

18. The method of claim 17 , wherein the composition forms a gel within about 20 minutes after injection into the bladder.

19. The method of claim 9 , wherein the concentration of xanthan gum is approximately 1% by weight, wherein the xanthan gum has a molecular weight between 1×10 6 and 15×10 6 Da, and wherein the xanthan gum has a viscosity between 800 and 1200 cP, and
wherein the composition further includes at least one of a carboxymethyl cellulose with a molecular weight of approximately 250,000 Da and a viscosity between 400 and 800 cP or a carboxymethyl cellulose with a molecular weight of approximately 700,000 Da and a viscosity between 1500 and 3000 cP.

Assignees

• Boston Scient Scimed Inc

Inventors

• Nagale Sandra
• SHREEVE David
• Boden Mark
• Zoll Jonathan
• Harrah Timothy
• Kangas Steven
• Seethamraju Kasyap
• Cavallaro Deanna
• Phelan Martin

Classifications

• A61L27/52

  Hydrogels or hydrocolloids · CPC title

• A61L2430/22

  for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus · CPC title

• A61L2400/06

  Flowable or injectable implant compositions · CPC title

• A61L27/20 Primary

  Polysaccharides · CPC title

• C08L5/00

  Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00 · CPC title